Dermatology
Pediatric Dermatology Consult
A 4-month-old male was referred for a 3-week history of an itchy generalized rash that started on the neck
Referred for consultation is an infant with a 3-week history of generalized rash.
Latest News
Impact of Pregnancy on Rosacea Unpredictable, Study Suggests
Researchers conducted a telephone survey of 39 women diagnosed with rosacea prior to becoming pregnant who were admitted to Oregon Health &...
Latest News
Study Identifies Cardiovascular Comorbidities Associated With Dermatomyositis
"Our findings are important both for prognosis and clinical care," the authors concluded.
Latest News
Myo-inositol is one of the components of an integrative approach to acne
Myo-inositol has been well-studied in patients with polycystic ovary syndrome (PCOS), demonstrating an ability to improve the metabolic profile...
Latest News
FDA Gives Nod to Berdazimer Gel for Molluscum Contagiosum
Approval of berdazimer, a topical nitric oxide–releasing agent, was based largely on a 12-week pivotal phase 3 trial known as B-SIMPLE4.
Latest News
AAAAI/ACAAI Joint Task Force Issues Updated ‘Practice-Changing’ Guidelines to Manage AD
“There’s something in here for all clinicians — from primary care to AD experts — and patients may benefit as well, so the key individual...
Latest News
Expert Highlights Biologics in the Pipeline for Atopic Dermatitis
“It’s truly an exciting time because we have a lot of different treatments that target IL-4 and other receptors,” Dr. David Rosmarin said.
Latest News
US Dermatologic Drug Approvals Rose Between 2012 and 2022
The study authors identified 52 new drug applications and 26 supplemental new indications approved by the FDA for dermatologic indications between...
Latest News
Public Citizen seeks stronger warning for Botox, related products
The current warning does not contain any information about the potential need for antitoxin and downplays the need for giving antitoxin in the...
From the Journals
Experimental Topical Drug Shows Promise for Atopic Dermatitis and Plaque Psoriasis
PDE4 inhibitors are a promising therapeutic target for inflammatory diseases because “they can increase cyclic adenosine monophosphate levels and...
Conference Coverage
Expert Frames Factors to Consider Among Atopic Dermatitis Treatment Options
“There isn’t going to be a one-size-fits-all approach.”